Anti-nerve growth factor in pain management: current evidence
David S Chang,1 Eugene Hsu,2 Daniel G Hottinger,1 Steven P Cohen1,3–5 1Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 2Clinical Excellence Research Center, Stanford University School of Medicine, Stanford, CA, 3Departmen...
Main Authors: | Chang DS, Hsu E, Hottinger DG, Cohen SP |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-06-01
|
Series: | Journal of Pain Research |
Subjects: | |
Online Access: | https://www.dovepress.com/anti-nerve-growth-factor-in-pain-management-current-evidence-peer-reviewed-article-JPR |
Similar Items
-
Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis
by: Mona K Patel, et al.
Published: (2018-01-01) -
Back pain
by: Iwan Milanow
Published: (2014-09-01) -
Differential diagnosis of neuropathic pain
by: Yu. N. Bykov, et al.
Published: (2015-03-01) -
Pain in the Blood? Envisioning Mechanism-Based Diagnoses and Biomarkers in Clinical Pain Medicine
by: Emmanuel Bäckryd
Published: (2015-03-01) -
Tetrahydrocannabinol and Cannabidiol for Pain Treatment—An Update on the Evidence
by: Kawthar Safi, et al.
Published: (2024-01-01)